Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study
-
Published:2021-11
Issue:
Volume:157
Page:361-372
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Umeda Yoshiyasu, Yoshikawa Shusuke, Kiniwa Yukiko, Maekawa TakeoORCID, Yamasaki Osamu, Isei Taiki, Matsushita ShigetoORCID, Nomura Motoo, Nakai Yasuo, Fukushima Satoshi, Saito Shintaro, Takenouchi Tatsuya, Tanaka Ryo, Kato Hiroshi, Otsuka Atsushi, Matsuya Taisuke, Baba Natsuki, Nagase KotaroORCID, Inozume TakashiORCID, Onuma Takehiro, Kuwatsuka YutakaORCID, Fujimoto Noriki, Kaneko Takahide, Onishi Masazumi, Namikawa KenjiroORCID, Yamazaki Naoya, Nakamura YasuhiroORCID
Funder
Taiho Pharmaceutical Meso Scale Diagnostics Eisai Novartis Pharma Bristol-Myers Squibb Novartis Merck Sharp and Dohme
Subject
Cancer Research,Oncology
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|